Advertisement

Endothelin pp 221-237 | Cite as

Endothelin in Human Disease. II: Shock, Pulmonary Hypertension, and Congestive Heart Failure

  • Duncan J. Stewart
Part of the Clinical Physiology Series book series (CLINPHY)

Abstract

Since the identification of endothelin by Yanagisawa and coworkers less than four years ago, there has been considerable interest in defining the molecular biology of endothelin production and its biological properties. It is perhaps indicative of the times that our understanding of the physiological role of endothelin has lagged considerably behind our knowledge of its molecular biology.29 Although described in detail in accompanying chapters, some crucial aspects of endothelin’s biological activity relating to its possible physiological and pathophysiological importance are briefly reviewed here. Unless otherwise specified, the endothelin referred to in this chapter is endothelin-1, the principal endothelin product of vascular endothelium. When appropriate, endothelin-2 and endothelin-3 will be specified.

Keywords

Pulmonary Hypertension Atrial Natriuretic Peptide Cardiogenic Shock Heart Circ Vasoconstrictor Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ando, K., Y. Hirata, M. Shichiri, T. Emori, and F. Marumo. Presence of immunoreactive endothelin in human plasma. Febs Lett. 245: 164–166, 1989.CrossRefPubMedGoogle Scholar
  2. 2.
    Armstead, W. M., R. Mirro, C. W. Leffler, and D. W. BusIja. Influence of endothelin on piglet cerebral microcirculation. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H707 - H710, 1989.Google Scholar
  3. 3.
    Asano, T., I. Ikegaki, Y. SuzuKI, S.-I. Satoh, and M. Shibuya. Endothelin and the production of cerebral vasospasm in dogs. Biochem. Biophys. Res. Commun. 159: 1345–1351, 1989.Google Scholar
  4. 4.
    Badr, K. F., J. J. Murray, M. D. Breyer, K. Takahashi, T. Inagami, R. C. Harris, M. Schwartzberg, and J. Ebert. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: elucidation of signal transduction pathways. J. Clin. Invest. 83: 336–342, 1989.CrossRefPubMedGoogle Scholar
  5. 4a.
    a.Bassenge, E., R. Busse, and U. Porn,. Abluminal release and assymetric response of rabbit arterial wall to endothelium-derived relaxing factor. Circ. Res. 61 (Suppl. 5): 68–73, 1987.Google Scholar
  6. 5.
    Boulanger, C., and T. F. LÜScher. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587–590, 1990.CrossRefPubMedGoogle Scholar
  7. 6.
    Brown, K. D., and C. J. Littlewood. Endothelin stimulates Dna synthesis in Swiss 3T3 cells: synergy with polypeptide growth factors. Biochem. J. 263: 977–980, 1989.PubMedGoogle Scholar
  8. 7.
    Cairns, H. S., M. E. Rogerson, L. D. Fairbanks, G. H. Neild, and J. Westwick. Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney. Br. J. Pharmacol. 98: 155–160, 1989.CrossRefPubMedGoogle Scholar
  9. 8.
    Cernacek, P., and D. J. Stewart. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem. Biophys. Res. Commun. 161: 562–567, 1989.CrossRefPubMedGoogle Scholar
  10. 9.
    Chester, A. H., M. R. Dashwood, J. G. Clarke, S. W. Larkin, G. J. Davies, S. Tadjkarimi, A. Maseri, and M. H. Yacoub. Influence of endothelin on human coronary arteries and localization of its binding sites. Am. J. Cardiol. 63: 1395–1398, 1989.CrossRefGoogle Scholar
  11. 10.
    Clarke, J. G., N. Benjamin, S. W. Larkin, D. J. Webb, G. J. Davies, and A. Maseri. Endothelin is a potent long-lasting vasoconstrictor in men. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H2033 — H2035, 1989.Google Scholar
  12. 11.
    Clozel, J.-P., and M. Clozel. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ. Res. 65: 1193–1200, 1989.CrossRefPubMedGoogle Scholar
  13. 12.
    Cocks, T. M., N. L. Faulkner, K. Sudhir, and J. Angus. Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur. J. Pharmacol. 171: 17–24, 1989.CrossRefPubMedGoogle Scholar
  14. 13.
    Costello, K.B., Stewart, D. J., and Baffour, R. Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery. Eur. J. Pharmacol. 186: 311–314, 1990.CrossRefPubMedGoogle Scholar
  15. 14.
    DE Nucci, G., R. Thomas, P. D’Orleans-Juste, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. Usa 85: 9797–9800, 1988.Google Scholar
  16. 15.
    Dubin, D., R. E. Pratt, J. P. Cooke, and V. J. DzAU. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. Clin. Res. 37: 517A, 1989.Google Scholar
  17. 16.
    EzRA, D., R. E. Goldstein, J. F. Czaja, and G. Z. Feuerstein. Lethal ischemia due to intracoronary endothelin in pigs. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H339 — H343, 1989.Google Scholar
  18. 17.
    Faraci, F. M. Effects of endothelin and vasopressin on cerebral blood vessels. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H799 — H803, 1989.Google Scholar
  19. 18.
    Firth, J. D., P. J. Ratcliffe, A. E. G. Raine, and J. G. G. Ledingham. Endothelin: an important factor in acute renal failure. Lancet 2: 1179–1182, 1988.CrossRefPubMedGoogle Scholar
  20. 19.
    Folta, A., I. G. Joshua, and R. C. Webb. Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig. Life Sci. 45: 2627–2635, 1989.CrossRefPubMedGoogle Scholar
  21. 20.
    Fukuda, K., S. Hori, M. Kusuhara, T. Satoh, S. Kyotani, S. Handa, Y. Nakamura, H. OoNO, and K. Yamaguchi. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur. J. Pharmacol. 165: 301–304, 1989.CrossRefPubMedGoogle Scholar
  22. 21.
    Fukuda, Y., Y. Hirata, H. Yoshimi, T. KoJima, Y. Kobayashi, M. Yanagisawa, and T. MA-Saki. Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem. Biophys. Res. Commun. 155: 167–172, 1988.CrossRefPubMedGoogle Scholar
  23. 22.
    Furchgott, R. F., and P. M. Vanhoutte. Endothelium-derived relaxing and contracting factors. Faseb J. 3: 2007–2018, 1989.PubMedGoogle Scholar
  24. 23.
    Gardiner, S. M., A. M. Compton, T. Bennett, R. M. J. Palmer, and S. Moncada. NGmonomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur. J. Pharmacol. 171: 237–240, 1989.CrossRefPubMedGoogle Scholar
  25. 24.
    Giaid, A., S. J. Gibson, N. B. N. Ibrahim, S. Legon, S. R. Bloom, M. Yanagisawa, T. MA-Saki, I. M. Varndell, and J. M. PoLak. Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. Usa 86: 7634–7638, 1989.CrossRefPubMedGoogle Scholar
  26. 25.
    Gillespie, M. N., J. O. OwAsoyo, I. F. Mcmurtry, and R. F. O’Brien. Sustained vasoconstriction by a peptidergic substance released from endothelial cells in culture. J. Pharmacol. Exp. Ther. 236: 339–343, 1986.PubMedGoogle Scholar
  27. 26.
    Godfraind, T., D. Mennig, G. Bravo, C. Chalant, and P. Jaumin. Inhibition by amlodipine of activity evoked in isolated human coronary arteries by endothelin, prostaglandin F2, and depolarization. Am. J. Cardiol. 64: 58I - 64I, 1989.CrossRefPubMedGoogle Scholar
  28. 27.
    Goetz, K. L., B. C. Wang, J. B. Madwed, J. L. Zhu, and R. J. Leadley, JR. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24 ): R1064 — R1068, 1988.Google Scholar
  29. 28.
    Hickey, K. A., G. M. Rubanyi, R. J. Paul, and R. F. Highsmith. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248 (Cell Physiol. 17 ): C550–0556, 1985.Google Scholar
  30. 29.
    Hiley, C. R. Functional studies on endothelin catch up with molecular biology. Tips 10: 47–49, 1989.PubMedGoogle Scholar
  31. 30.
    Hiley, C. R., S. A. Douglas, and M. D. Randall. Pressor effects of endothelin-1 and some analogs in the perfused superior mesenteric arterial bed of the rat. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S197 — S199, 1989.CrossRefPubMedGoogle Scholar
  32. 31.
    Hirata, Y., K. Itoh, K. Ando, M. Endo, and F. Marumo. Plasma endothelin levels during surgery. N. Engl. J. Med. 321: 1686–1686, 1989.PubMedGoogle Scholar
  33. 32.
    Hoffman, A., E. Grossman, K. P. Oshman, E. Marks, and H. R. Keiser. Endothelin induces an initial increase in cardiac output associated with selective vasodilation in rats. Life Sci. 45: 249–255, 1989.CrossRefPubMedGoogle Scholar
  34. 33.
    Hu, J. R., U. G. Berninger, and R. E. Lang. Endothelin stimulates atrial natriuretic peptide (Anp) release from rat atria. Eur. J. Pharmacol. 158: 177–178, 1988.CrossRefPubMedGoogle Scholar
  35. 34.
    IshikawA, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am. J. Physiol. 255 (Heart Circ. Physiol. 24 ): H970 - H973, 1988.Google Scholar
  36. 35.
    Karwatowska-Prokopczuk, E., and A. Wennmalm. Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ. Res. 66: 46–54, 1990.Google Scholar
  37. 36.
    Kauser, K., G. M. RuBanyi, and D. R. Harder. Endothelium-dependent modulation of endothelin-induced vasoconstriction and membrane depolarization in cat cerebral arteries. J. Pharmacol. Exp. Ther. 252: 93–97, 1990.PubMedGoogle Scholar
  38. 37.
    King, A. J., B. M. Brenner, and S. Anderson. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25 ): F1051 - F1058, 1989.Google Scholar
  39. 38.
    Komuro, I., H. Kurihara, T. Sugiyama, F. Takaku, and Y. Yazaki. Endothelin stimulates cfos and c-myc expression and proliferation of vascular smooth muscle cells. Febs Lett. 238: 249–252, 1988.CrossRefPubMedGoogle Scholar
  40. 39.
    Kon, V., T. YosHIoKA, A. FoGO, and I. Ichikawa. Glomerular actions of endothelin in vivo. J. Clin. Invest. 83: 1762–1767, 1989.CrossRefPubMedGoogle Scholar
  41. 40.
    Koseki, C., M. Imai, Y. Hirata, M. Yanagisawa, and T. Masaki. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25 ): R858 - R866, 1989.Google Scholar
  42. 41.
    Kubac, G., P. Cernacek, F. Mohamed, and D. J. Stewart. Plasma endothelin (ET) is elevated in the early hours following myocardial infarction (MI): possible diagnostic and prognostic implications, abstracted. J. Hypertens. 8 (Suppl. 3): S4, 1990.Google Scholar
  43. 42.
    Larkin, S. W., J. G. Clarke, B. E. Keogh, L. Araujo, C. Rhodes, G. J. Davies, K. M. Taylor, and A. Maseri. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am. J. Cardiol. 64: 956–958, 1989.Google Scholar
  44. 43.
    Levy, R. D., D. Langleben, P. Cernacek, and D. J. Stewart. Increased plasma levels of the endothelium-derived vasoconstrictor endothelin in pulmonary hypertension: marker or mediator of disease?, abstracted. Am. Rev. Respir. Dis. 141: A889, 1990.CrossRefGoogle Scholar
  45. 44.
    LI, K., Stewart, D. J., and Rouleau, J.-L. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Circ. Res. 69 (in press), 1991.Google Scholar
  46. 45.
    Lippton, H., J. Goff, and A. Hyman. Effects of endothelin in the systemic and renal vascular beds in vivo. Eur. J. Pharmacol. 155: 197–199, 1988.CrossRefPubMedGoogle Scholar
  47. 46.
    LipvroN, H. L., T. A. Hauth, W. R. Summer, and A. L. Hyman. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J. Appl. Physiol. 66: 1008–1012, 1989.Google Scholar
  48. 47.
    Loutzenhiser, R., M. Epstein, K. Hayashi, and C. Horton. Direct visualization of effects of endothelin on the renal microvasculature. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27 ): F61 - F68, 1990.Google Scholar
  49. 48.
    Lopez-Farr, A., I. Montan S., I. Millas, And J. M. Lopez-NovoA. Effect of endothelin on renal function in rats. Eur. J. Pharmacol. 163: 187–189, 1989.Google Scholar
  50. 49.
    Maggi, C. A., S. Giuliani, R. Patacchini, P. Santicioli, D. Turini, G. Barbanti, and A. Melt. Potent contractile activity of endothelin on the human isolated urinary bladder. Br. J. Pharmacol. 96: 755–757, 1989.CrossRefPubMedGoogle Scholar
  51. 50.
    Maggi, C. A., R. Patacchini, S. Giuliani, and A. Melt. Potent contractile effect of endothelin in isolated guinea-pig airways. Eur. J. Pharmacol. 160: 179–182, 1989.CrossRefPubMedGoogle Scholar
  52. 51.
    Masaoka, H., R. Suzuki, Y. Hirata, T. Emori, F. Marumo, and K. Hirakawa. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2: 1402–1402, 1989.CrossRefPubMedGoogle Scholar
  53. 51a.
    Mcmahon, E. G., M. A. Palomo, W. M. Moore, J. F. Mcddonald, and M. K. Stern. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1–39) in vivo and conversion of big endothelin-1-(1–39) to endothelin-1-(1–21) in vitro. Proc. Natl. Acad. Sci. Usa 88: 703–707, 1991.CrossRefPubMedGoogle Scholar
  54. 52.
    Miller, W. L., M. M. Redfield, and J. C. Burnett, JR. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317–320, 1989.CrossRefPubMedGoogle Scholar
  55. 53.
    Miyauchi, T., M. Yanagisawa, N. Suzuki, K. Iida, Y. Sugishita, M. Fujino, T. Saito, K. Goto, and T. Masaki. Venous plasma concentrations of endothelin in normal and hypertensive subjects, abstracted. Circulation 80: II-573-II-573, 1989.Google Scholar
  56. 54.
    Miyauchi, T., M. Yanagisawa, T. Tomizawa, Y. Sugishita, N. Suzuki, M. Fujino, R. Aji-Google Scholar
  57. Saka, K. GoTO, and T. Masaki. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2: 53–54, 1989.Google Scholar
  58. 55.
    Moghtader, S., P. Belichard, A. Calderone, J. L. Rouleau, and D. J. Stewart. Endothelin-induced coronary vasoconstriction is enhanced by experimental heart failure in dogs, abstracted. Faseb J. 4: A960, 1990.Google Scholar
  59. 56.
    Morel, D. R., J. S. Lacroix, A. Hemsen, D. A. Steinig, J.-F. Pittet, and J. M. Lundberg. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol. 167: 427–428, 1989.CrossRefPubMedGoogle Scholar
  60. 57.
    Morishita, R., J. Higaki, and T. Ogihara. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adreno-capsular cells. Biochem. Biophys. Res. Commun. 160: 628–632, 1989.CrossRefPubMedGoogle Scholar
  61. 58.
    Nakaki, T., M. Nakayana, S. Yamamoto, and R. Kato. Endothelin-mediated stimulation of Dna synthesis in vascular smooth muscle. Biochem. Biophys. Res. Commun. 158: 880–883, 1989.CrossRefPubMedGoogle Scholar
  62. 59.
    Ohtsuka, M., Y. Uchida, M. Saotoma, N. Ninomiya, Y. Ishii, and S. Masugawa. Endothelin exerts to human pulmonary artery as a vasoconstrictor in vitro, abstracted. Am. Reu. Respir. Dis. 139A: 51–51, 1989.Google Scholar
  63. 60.
    Otsuka, A., H. Mikami, K. Katahira, T. Tsunetoshi, K. Minamitani, and T. Ogihara. Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs. Acta Endocrinol. (Copenh) 121: 361–364, 1989.Google Scholar
  64. 61.
    Pernow, J., J.-F. Boutier, A. Franco-Cereceda, J. S. Lacroix, R. Matran, and J. M. Lundberg. Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. Acta Physiol. Scand. 134: 573–574, 1988.Google Scholar
  65. 62.
    Pernow, J., A. Hemsen, and J. M. Lundberg. Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol. Scand. 137: 317–318, 1989.CrossRefPubMedGoogle Scholar
  66. 63.
    PoHL, U., and R. Busse. Differential vascular sensitivity to luminally and adventitially applied endothelin-1. J. Cardiouasc. Pharmacol. 13 (Suppl. 5): S188 - S190, 1989.Google Scholar
  67. 64.
    Rae, G. A., M. Trybulec, G. DE Nucci, and J. R. Vane. Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen. J. Cardiouasc. Pharmacol. 13 (Suppl. 5): S89 - S92, 1989.CrossRefGoogle Scholar
  68. 65.
    Rakugi, H., M. Nakamaru, H. Saito, J. Higaki, and T. Ogihara. Endothelin inhibits renin release from isolated rat glomeruli. Biochem. Biophys. Res. Commun. 155: 1244 1247, 1988.Google Scholar
  69. 66.
    Reeves, J. T., B. M. Grove, and D. Turikevich. The case for treatment of selected patients with primary pulmonary hypertension. Am. Rev. Respir. Dis. 134: 342–346, 1986.PubMedGoogle Scholar
  70. 67.
    Reynolds, E. E., L. L. S. Mok, and S. Kurokawa. Phorbol ester dissociates endothelinstimulated phosphoinositide hydroylysis and arachidonic acid release in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 160: 868–873, 1989.CrossRefPubMedGoogle Scholar
  71. 68.
    Rimar, S., and C. N. Gillis. Differential uptake of endothelin by rabbit coronary and pulmonary circulations, abstracted. Circulation 80-II: 213–213, 1989.Google Scholar
  72. 69.
    Ryan, U. S., and J. Frokjager-Jensen. Pulmonary endothelium and processing of pulmonary solutes: structure and function. In: The Pulmonary Circulation and Acute Lung Injury, edited by S. I. Said. Mount Kisco, NY: Futura, p. 37–60, 1985.Google Scholar
  73. 70.
    Ryan, U. S., M. K. Glassberg, and K. B. NoLop. Endothelin-1 from pulmonary artery and microvessels acts on vascular and airway smooth muscle. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S57 - S62, 1989.CrossRefPubMedGoogle Scholar
  74. 71.
    Saito, Y., K. Nakao, M. Mukoyama, and H. Imura. Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 322: 205–205, 1990.PubMedGoogle Scholar
  75. 72.
    Salminen, K., I. Tikkanen, O. Saijonmaa, M. Nieminen, F. Fyhrquist, and M. H. Frick. Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet 2: 747–747, 1989.CrossRefPubMedGoogle Scholar
  76. 73.
    Schomisch-Moravec, C., E. E. Reynolds, R. W. Stewart, and M. Bond. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 159: 14–18, 1989.Google Scholar
  77. 74.
    Shah, A. M., M. J. Lewis, and A. H. Henderson. Inotropic effects of endothelin in ferret ventricular myocardium. Eur. J. Pharmacol. 163: 365–367, 1989.CrossRefPubMedGoogle Scholar
  78. 75.
    Shichiri, M., Y. Hirata, K. Ando, K. Kanno, T. Emori, K. Ohta, and F. Marumo. Postural change and volume expansion affect plasma endothelin levels. Jama 263: 661–661, 1990.CrossRefPubMedGoogle Scholar
  79. 76.
    Shigeno, T., T. Mima, K. Takakura, M. Yanagisawa, A. Saito, K. GoTO, and T. Masaki. Endothelin-1 acts in cerebral arteries from the adventitial but not from the luminal side. J. Cardiouasc. Pharmacol. 13 (Suppl. 5): S174 - S176, 1989.CrossRefGoogle Scholar
  80. 77.
    Shinmi, O., S. Kimura, T. Sawamura, Y. Sugita, T. Yoshizawa, Y. Uchiyama, M. Yanagi-Google Scholar
  81. Sawa, K. GoTO, T. Masaki, and I. Kanazawa. Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem. Biophys. Res. Commun. 164: 587–593, 1989.CrossRefGoogle Scholar
  82. 78.
    Simonson, M. S., S. Wann, P. Men, G. R. Dubyak, M. Kester, Y. Nakazato, J. R. Sedor, and M. J. Dunn. Endothelin stimulates phospholipase C, Na ’/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J. Clin. Invest. 83: 708–712, 1989.CrossRefPubMedGoogle Scholar
  83. 79.
    Sirvio, M.-L., K. Metsarinne, O. Saijonmaa, and F. Fyhrquist. Tissue distribution and half-life of 125I-endothelin in the rat: importance of pulmonary clearance. Biochem. Biophys. Res. Commun. 167: 1191–1195, 1990.CrossRefPubMedGoogle Scholar
  84. 80.
    Stelzner, T. J., M. Yanagisawa, T. Sakurai, K. Sato, S. Webb, M. Zamora, I. F. McMurtry, J. H. Fisher, and R. F. O’Brien. Increased lung preproendothelin (preET-1) mRna expression in rats with pulmonary hypertension, abstracted. Faseb J. 4: A1147 - A1147, 1990.Google Scholar
  85. 81.
    Stewart, D. J., and R. Baffour. Ischemia-reperfusion potentiates endothelin-induced constriction in the coronary resistance bed. In: Endothelium-Derived Contracting Factors,edited by G. M. Rubanyi, and P. M. Vanhoutte. Basel: Karger, 1990, p. 212220.Google Scholar
  86. 82.
    Stewart, D. J., and R. Baffour. Functional state of the endothelium determines the response to endothelin in the coronary circulation. Cardiovasc. Res. 24: 7–12, 1990.CrossRefPubMedGoogle Scholar
  87. 82a.
    Stewart, D. J., P. Cernacek, and J.-L. Rouleau. High endothelin levels in heart failure and loss of normal response to postural change, abstracted. Circulation 82: Iii 725, 1990.Google Scholar
  88. b. Stewart, D. J., G. Kubac, K. B. Costello, And P. Cernacek. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18: (in press), 1991.Google Scholar
  89. 83.
    Stewart, D., L. Langleben, P. Cernacek, and K. Cianflone. Endothelin release is inhibited by coculture of endothelial cells with cells of vascular media. Am. J. Physiol. 259 (Heart Circ. Physiol. 28 ): H1928–1932, 1990.Google Scholar
  90. 84.
    Stewart, D. J., R. D. Levy, P. Cernacek, and D. Langleben. Increased plasma endothelin1 in pulmonary hypertension: marker or mediator of disease. Ann. Intern. Med. 114: 464–469, 1991.CrossRefPubMedGoogle Scholar
  91. 85.
    Sugiura, M., T. Inagami, and V. Kon. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161: 1220–1227, 1989.CrossRefPubMedGoogle Scholar
  92. 85a.
    Suzuki H., S. Sato, Y. Suzuki, M. Oka, T. Tsuchiya, I. Lino, T. Yamanaka, N. Ishihara, and S. Shimoda. Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Ann. Med. 22: 233–236, 1990.Google Scholar
  93. 86.
    SuzUki, N., H. Matsumoto, C. Kitada, T. Masaki, and M. Fujino. A sensitive sandwich-enzyme immunoassay for human endothelin. J. Immunol. Methods 118: 245–250, 1989.Google Scholar
  94. 87.
    Tabuchi, Y., M. Nakamaru, H. Rakugi, M. Nagano, H. Mikami, and T. Ogihara. Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem. Biophys. Res. Commun. 161: 803–808, 1989.CrossRefPubMedGoogle Scholar
  95. 88.
    Tabuchi, Y., M. Nakamaru, H. Rakugi, M. Nagano, and T. Ogihara. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem. Biophys. Res. Commun. 159: 1304–1308, 1989.CrossRefPubMedGoogle Scholar
  96. 89.
    Takagi, M., H. Tsukada, H. Matsuoka, and S. Yagi. Inhibitory effect of endothelin on renin release in vitro. Am. J. Physiol. 257 (Endocrinol. Metab. 20 ): E833 - E838, 1989.Google Scholar
  97. 90.
    Takuwa, N., Y. Takuwa, M. Yanagisawa, K. Yamashita, and T. Masaki. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264: 7856–7861, 1989.PubMedGoogle Scholar
  98. 91.
    Thiemermann, C., P. S. Lidbury, G. R. Thomas, and J. R. Vane. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S138 - S142, 1989.CrossRefPubMedGoogle Scholar
  99. 92.
    Tomita, K., K. Ujiie, T. Nakanishi, S. Tomura, O. Matsuda, K. Ando, M. Shichiri, Y. Hirata, and F. Marumo. Plasma endothelin levels in patients with acute renal failure. N. Engl. J. Med. 321: 1127–1127, 1989.PubMedGoogle Scholar
  100. 93.
    Totsune, K., T. Mouri, K. Takahashi, M. Ohneda, M. Sone, T. Saito, and K. Yoshinaga. Detection of immunoreactive endothelin in plasma of hemodialysis patients. Febs Lett. 249: 239–242, 1989.CrossRefPubMedGoogle Scholar
  101. 94.
    Touvay, C., B. Vilain, F. Pons, P.-E. Chabrier, J. M. Mencia-Huerta, and P. Braquet. Bronchopulmonary and vascular effect of endothelin in the guinea-pig. Eur. J. Pharmacol. 176: 23–33, 1990.CrossRefPubMedGoogle Scholar
  102. 95.
    Tsuchiya, K., M. Naruse, T. Sanaka, K. Naruse, Y. Kato, Z. P. Zeng, K. Nitta, K. Shizume, H. Demura, and N. Sugino. Effects of endothelin on renal hemodynamics and excretory functions in anesthetized dogs. Life Sci. 46: 59–65, 1990.CrossRefPubMedGoogle Scholar
  103. 96.
    Uchida, Y., H. Ninomiya, M. Saotome, A. Nomura, M. Ohtsuka, M. Yanagisawa, K. Goto, T. Masaki, and S. Hasegawa. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur. J. Pharmacol. 154: 227–228, 1988.CrossRefPubMedGoogle Scholar
  104. 97.
    Vanhoutte, P. M. Endothelium dependent contractions. Blood Vessels 28: 74–83, 1991.PubMedGoogle Scholar
  105. 98.
    Vierhapper, H., O. Wagner, P. Nowotny, and W. Waldhaeusl. Effect of endothelin-1 in man. Circulation 81: 1415–1418, 1990.CrossRefPubMedGoogle Scholar
  106. 99.
    Vigne, P., M. Lazdunski, and C. Frelin. The inotropic effect of endothelin-1 on rat atria involves hydrolysis of phosphatidylinositol. Febs Lett. 249: 143–146, 1989.CrossRefPubMedGoogle Scholar
  107. 100.
    Warner, T. D., G. DE NucCI, and J. R. Vane. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol. 159: 325–326, 1989.CrossRefPubMedGoogle Scholar
  108. 101.
    Warner, T. D., J. A. Mitchell, G. DE NucCi, and J. R. Vane. Endothelin-1 and endothelin3 release Edrf from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): 585–888, 1989.Google Scholar
  109. 101a.
    Warrens, A. N., M. J. D. Cassidy, K. Takahashi, M. A. Ghatei, and S. R. Bloom. Endothelium in renal failure. Nephrol. Dial. Transplant. 5: 418–422, 1990.CrossRefPubMedGoogle Scholar
  110. 102.
    Webb, D. J., and J. R. Cockcroft. Plasma immunoreactive endothelin in uraemia. Lancet 1: 1211–1211, 1989.CrossRefPubMedGoogle Scholar
  111. 103.
    Wiklund, N. P., A. Ohl N, and B. Cederqvist Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery. Acta Physiol. Scand. 134: 311–312, 1988.CrossRefPubMedGoogle Scholar
  112. 104.
    Wiklund, N. P., A. Ohl N, C. U. Wiklund, B. Cederqvist, P. Hedqvist, and L. E. GusTafsson. Neuromuscular actions of endothelin on smooth, cardiac and skeletal muscle from guinea-pig, rat and rabbit. Acta Physiol. Scand. 137: 399–407, 1989.CrossRefPubMedGoogle Scholar
  113. 105.
    Winquist, R. J., A. L. Scott, and G. P. Vlasuk. Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. Hypertension 14: 111–114, 1989.CrossRefPubMedGoogle Scholar
  114. 106.
    Xuan, Y.-T., A. R. Whorton, E. Shearer-Poor, J. Boyd, and W. D. Watkins. Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. Biochem. Biophys. Res. Commun. 164: 326–332, 1989.Google Scholar
  115. 107.
    Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.CrossRefPubMedGoogle Scholar
  116. 108.
    Yang, Z., F. R. BÜHler, D. Diederich, and T. F. Luscher. Different effects of endothelin1 on cAmp-and cGmp-mediated vascular relaxation in human arteries and veins: comparison with norepinephrine. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S129 - S131, 1989.CrossRefPubMedGoogle Scholar
  117. 109.
    Yasuda, M., M. Kohno, A. Tahara, H. Itagane, I. Toda, K. Akioka, M. Teragaki, H. Oku, K. Takeuchi, and T. Takeda. Circulating immunoreactive endothelin in ischemic heart disease. Am. Heart J. 119: 801–806, 1990.CrossRefPubMedGoogle Scholar
  118. 110.
    Yoshizawa, T., S. Kimura, I. Kanazawa, Y. Uchiyama, M. Yanagisawa, and T. Masaki. Endothelin localizes in the dorsal horn and acts on the spinal neurones: possible involvement of dihydropyridine-sensitive calcium channels and substance P release. Neurosci. Lett. 10: 179–184, 1989.CrossRefGoogle Scholar
  119. 111.
    Zeidel, M. L., H. R. Brady, B. C. Kone, S. R. Gullans, and B. M. Brenner. Endothelin, a peptide inhibitor of Na -K -Atpase in intact renal tubular epithelial cells. Am. J. Physiol. 257 (Cell Physiol. 26): C1101 - C1107, 1989.PubMedGoogle Scholar

Copyright information

© American Physiological Society 1992

Authors and Affiliations

  • Duncan J. Stewart

There are no affiliations available

Personalised recommendations